Development of Technologies for Efficient In Vivo Prime Editing
高效体内 Prime 编辑技术的开发
基本信息
- 批准号:10580008
- 负责人:
- 金额:$ 53.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:Amyotrophic Lateral SclerosisBasic ScienceBiologicalBiotechnologyCRISPR/Cas technologyCarrying CapacitiesCellsChromosomal translocationClinical ResearchClinical TrialsComputational BiologyCultured CellsDNADNA Double Strand BreakDNA SequenceDataDevelopmentElementsEngineeringEvaluationExperimental DesignsFutureGene DeliveryGenesGenomeGenomic DNAGenomic approachImmune responseKnowledgeMachine LearningMediatingMethodologyMethodsModificationMutationNonsense MutationOpen Reading FramesOutcomePathogenicityPeptide Signal SequencesPositioning AttributeRegulatory ElementResearchResearch PersonnelRoleSiteSite-Directed MutagenesisSpecificitySystemTechnologyTestingTherapeuticTimeTissuesTrans-SplicingVariantadeno-associated viral vectorbasebase editorbiophysical techniquescell typecomputational suitedelivery vehicledesignexperienceexperimental studyflexibilitygene therapygenome editinghuman diseaseimmunogenicimprovedin vivoinnovationinsertion/deletion mutationinteinminiaturizemultidisciplinarynovelnucleaseparticlepostmitoticpredictive modelingpreventprime editingprime editorpromoterreconstitutionresponsesuccesstechnology developmenttechnology research and developmenttool
项目摘要
PROJECT SUMMARY
Genome editing is revolutionizing biomedicine and biotechnology by enabling the precise modification of
genomic DNA in living cells. While various genome-editing tools have been developed over the past decade, the
CRISPR-Cas9 system has emerged as a particularly versatile and efficient technology for editing DNA.
Nonetheless, limitations derived from its reliance on DNA double strand breaks (DSB), which can lead to
unpredictable editing outcomes and even chromosomal translocations, could limit its applications.
Base editors (BEs) and prime editors (PEs) are two novel classes of genome-editing tools capable of
introducing precise single-base conversion in DNA without the requirement of a DSB. PEs, in particular, provide
greater flexibility than BEs, owing to their ability to introduce any type of base conversion and even programable
small insertions and deletions. This expanded set of capabilities compared to other technologies makes PEs a
particularly promising platform for applications in biomedicine; however, the large size of PEs precludes their in
vivo delivery by AAV, a promising and effective gene delivery vehicle that is currently under evaluation in multiple
clinical trials.
To overcome these obstacles, we have created a split-PE platform that is compatible with AAV delivery and
have demonstrated the functionality of this approach in cultured cells. Despite this progress, there still remain
several critical challenges, which we here propose to overcome in order to optimize this technology for effective
and specific in vivo prime editing.
To accomplish this objective, we have assembled a multidisciplinary team with collective expertise in genome
editing (Dr. Perez-Pinera), AAV gene delivery (Dr. Gaj) and computational biology (Dr. Song). Our collaborative
efforts will yield an integrated and comprehensive PE toolset that will blend strategies for target identification and
editing optimization, with methods for reducing off-target effects and immune responses, thus priming this
technology for future in vivo applications.
Given that the flexibility of PEs has significantly expanded the number of actionable target sites that can be
genetically modified, we anticipate that the integrated technologies we develop will have large, direct and long-
lasting impact in biomedicine by enabling not only novel gene therapies, but also basic research. In particular,
our technology will provide investigators with biological tools that are uniquely capable of introducing mutations
within post-mitotic cells in vivo, which could be used to dissect functional elements or even determine the role of
pathogenic mutations in a cell- and tissue-specific manner. The technologies created by this application will thus
broadly impact biotechnology and biomedicine.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pablo Perez-Pinera其他文献
Pablo Perez-Pinera的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pablo Perez-Pinera', 18)}}的其他基金
Development of Technologies for Efficient In Vivo Prime Editing
高效体内 Prime 编辑技术的开发
- 批准号:
10184207 - 财政年份:2021
- 资助金额:
$ 53.63万 - 项目类别:
Development of Technologies for Efficient In Vivo Prime Editing
高效体内 Prime 编辑技术的开发
- 批准号:
10381534 - 财政年份:2021
- 资助金额:
$ 53.63万 - 项目类别:
Engineering platforms for editing RNA with single base resolution
单碱基分辨率 RNA 编辑工程平台
- 批准号:
9922944 - 财政年份:2018
- 资助金额:
$ 53.63万 - 项目类别:
相似海外基金
HNDS-R: Connectivity, Inclusiveness, and the Permeability of Basic Science
HNDS-R:基础科学的连通性、包容性和渗透性
- 批准号:
2318404 - 财政年份:2023
- 资助金额:
$ 53.63万 - 项目类别:
Standard Grant
Advancing the basic science of membrane permeability in macrocyclic peptides
推进大环肽膜渗透性的基础科学
- 批准号:
10552484 - 财政年份:2023
- 资助金额:
$ 53.63万 - 项目类别:
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications
用于疟疾显微镜的计算机视觉:用于基础科学和临床前应用的疟原虫自动检测和分类
- 批准号:
10576701 - 财政年份:2023
- 资助金额:
$ 53.63万 - 项目类别:
Bringing together communities and basic science researchers to build stronger relationships
将社区和基础科学研究人员聚集在一起,建立更牢固的关系
- 批准号:
480914 - 财政年份:2023
- 资助金额:
$ 53.63万 - 项目类别:
Miscellaneous Programs
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 53.63万 - 项目类别:
Australian Laureate Fellowships
Developing science communication on large scale basic science represented by accelerator science
发展以加速器科学为代表的大规模基础科学科学传播
- 批准号:
22K02974 - 财政年份:2022
- 资助金额:
$ 53.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
早期病变转化和基础科学研究协调和数据管理中心
- 批准号:
10517004 - 财政年份:2022
- 资助金额:
$ 53.63万 - 项目类别:
Basic Science Core - Biosafety & Biocontainment Core (BBC)
基础科学核心 - 生物安全
- 批准号:
10431468 - 财政年份:2022
- 资助金额:
$ 53.63万 - 项目类别: